Wellington Management Group
MNTA

Wellington Management Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Wellington Management Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,797,827
Closed -$160M – 2034
2020
Q2 		$160M Sell
4,797,827
-1,057,747
-18% -$33.7M 0.04% 409
2020
Q1 		$159M Buy
5,855,574
+260,382
+5% +$7.25M 0.04% 356
2019
Q4 		$110M Sell
5,595,192
-794,301
-12% -$12.7M 0.02% 541
2019
Q3 		$82.8M Sell
6,389,493
-519,904
-8% -$6.28M 0.02% 592
2019
Q2 		$86M Sell
6,909,397
-230,011
-3% -$3.05M 0.02% 605
2019
Q1 		$104M Sell
7,139,408
-212,686
-3% -$2.72M 0.02% 540
2018
Q4 		$81.2M Buy
7,352,094
+3,554,714
+94% +$49.5M 0.02% 571
2018
Q3 		$99.9M Sell
3,797,380
-13,054
-0.3% -$353K 0.02% 586
2018
Q2 		$77.9M Sell
3,810,434
-5,083,262
-57% -$109M 0.02% 659
2018
Q1 		$161M Buy
8,893,696
+991,400
+13% +$16.5M 0.04% 429
2017
Q4 		$110M Buy
7,902,296
+1,529,644
+24% +$20.7M 0.02% 539
2017
Q3 		$118M Buy
6,372,652
+1,380,640
+28% +$23.1M 0.03% 501
2017
Q2 		$84.4M Buy
+4,992,012
New +$76M 0.02% 569
2016
Q1 		– Sell
-99,760
Closed -$1.48M – 2273
2015
Q4 		$1.48M Buy
99,760
+3,910
+4% +$65.4K ﹤0.01% 1708
2015
Q3 		$1.57M Sell
95,850
-7,700
-7% -$158K ﹤0.01% 1712
2015
Q2 		$2.36M Buy
103,550
+880
+0.9% +$17.5K ﹤0.01% 1625
2015
Q1 		$1.56M Sell
102,670
-6,320
-6% -$82.1K ﹤0.01% 1752
2014
Q4 		$1.31M Sell
108,990
-6,750
-6% -$77.1K ﹤0.01% 1802
2014
Q3 		$1.31M Buy
115,740
+160
+0.1% +$1.82K ﹤0.01% 1765
2014
Q2 		$1.4M Hold
115,580
– – ﹤0.01% 1751
2014
Q1 		$1.35M Sell
115,580
-88,120
-43% -$1.49M ﹤0.01% 1769
2013
Q4 		$3.6M Sell
203,700
-3,200
-2% -$53.8K ﹤0.01% 1565
2013
Q3 		$2.98M Sell
206,900
-73,800
-26% -$1.13M ﹤0.01% 1563
2013
Q2 		$4.23M Buy
+280,700
New +$3.7M ﹤0.01% 1468

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group's MNTA Position: Q3 2020 in Review

Wellington Management Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 4,797,827 shares — an estimated $160M sold.

Wellington Management Group first reported a position in MNTA in Q2 2013 and held it in 24 quarters. The position peaked at $161M in Q1 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Wellington Management Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Wellington Management Group sold 4,797,827 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $160M.
  • Wellington Management Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 24 quarters.
  • Wellington Management Group's Momenta Pharmaceuticals, Inc. position peaked at $161M in Q1 2018.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Wellington Management Group's 13F filing for Q3 2020, filed 16 Nov 2020.